drug
AG-181
updated 6mo agoby $AGIO AGIOS PHARMACEUTICALS, INC.
community read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Trials studying AG-181
News(2)
- Agios axes 100-plus R&D roles while awaiting FDA decisionAfter the FDA delayed a decision for Agios Pharmaceuticals’ sickle cell disease candidate, the biopharma is letting go of more than 35% of its R&D employees.biospace · 13d ago
- Agios axes next-gen sickle cell candidate after it fails to best Novo’s assetAgios Pharmaceuticals’ sickle cell disease candidate didn’t prove any better than Novo Nordisk’s investigational PK activator or the biopharma’s own asset that is currently under FDA review for the…biospace · 4mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that